BY MARKETWIRE
-
A booming stock market listing: Medline rises more than 25%
This also gives the company, which is mainly owned by the private equity funds Blackstone, Carlyle Group, and Hellman & Friedman, a market value of more than USD 49 billion.
-
Bavarian Nordic appoints new vice chair
Bavarian Nordic has actually assigned Heidi Seeker as its brand-new vice chair while the look for added board participants proceeds.
-
Novo Nordisk receives Canadian approval for Wegovy against MASH
Ifølge Novo Nordisk emergency room Wegovy den eneste behandlingsmulighed, der emergency room godkendt af Wellness Canada til canadiske borgere med leversygdommen mash.
-
Sonova and Demant gained market share among US veterans in November
On the other hand, Danish listening device producers GN and WS Audiology shed market share in November.
-
Genmab completes acquisition of Dutch biotech company Merus
The procurement was revealed back in September and can currently be settled.
-
Zealand Pharma ready with new strategy: Aims to lead in obesity and metabolic disorders
The method will certainly exist at the business’s funding markets day, which occurs on Thursday.
-
Eli Lilly rumored to be interested in acquiring promising French biotech company
The firm just recently provided favorable information from a stage III test of a medicine for the intestinal tract illness ulcerative colitis.
-
US FDA likely to speed up evaluation of Eli Lilly’s weight loss pill
This is reported by information firm Reuters, which has actually seen inner records.
-
Genmab completes acquisition of Dutch biotech company Merus
The procurement was introduced back in September and can currently be settled.
-
Eli Lilly delivers positive data from next-generation obesity drug
According to Eli Lilly, the outcomes went beyond assumptions, and some people shed a lot weight that they left of the test.
